Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Assets Average (2018 - 2024)

Solid Biosciences (SLDB) has disclosed Assets Average for 7 consecutive years, with $221.4 million as the latest value for Q3 2024.

  • Quarterly Assets Average rose 13.7% to $221.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $221.4 million through Sep 2024, up 13.7% year-over-year, with the annual reading at $212.6 million for FY2023, 13.69% down from the prior year.
  • Assets Average hit $221.4 million in Q3 2024 for Solid Biosciences, down from $239.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $275.6 million in Q2 2021 to a low of $49.2 million in Q3 2020.
  • Historically, Assets Average has averaged $192.5 million across 5 years, with a median of $217.2 million in 2023.
  • Biggest five-year swings in Assets Average: plummeted 56.66% in 2020 and later soared 422.78% in 2021.
  • Year by year, Assets Average stood at $105.8 million in 2020, then soared by 127.4% to $240.7 million in 2021, then fell by 7.61% to $222.4 million in 2022, then decreased by 21.37% to $174.8 million in 2023, then grew by 26.64% to $221.4 million in 2024.
  • Business Quant data shows Assets Average for SLDB at $221.4 million in Q3 2024, $239.8 million in Q2 2024, and $206.8 million in Q1 2024.